Advancements in Image-Guided Radiotherapy for the Treatment of Lung Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 1764
Special Issue Editors
Interests: lung cancer; functional imaging; stereotactic body radiotherapy; radiomics; quality of life; biomarkers
Special Issue Information
Dear Colleagues,
Image-guided radiotherapy (IGRT) takes place at every step of the treatment in lung cancer, from treatment planning with fusion imaging, to daily in-room repositioning. Managing tumor and organ motion has been possible since the introduction of routine four-dimensional computed tomography (4DCT) use. The assessment of respiratory motion has been performed with “passive” techniques based on reconstruction images from 4DCT planning, or “active” techniques adapted to the patient's breathing. Additionally metabolic imaging has a great importance in radiotherapy planning, dose delivering and adaptive approach, with the aim to increase the accuracy in target definition and sparing of healthy tissues. Magnetic resonance imaging (MRI) and functional imaging also play an important role in lung cancer radiation and open the way for adaptive RT. Topics for this Special Issue include technical advances in RT and their clinical impact on lung cancer treatment.
Dr. François Lucia
Dr. Vincent Bourbonne
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- functional imaging
- stereotactic body radiotherapy
- radiomics
- biomarkers
- artificial intelligence
- magnetic resonance imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
